[Federal Register: July 8, 2003 (Volume 68, Number 130)]
[Notices]               
[Page 40686]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr08jy03-90]                         

-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

 
Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated January 27, 2003, and published in the Federal 
Register on February 6, 2003, (68 FR 6184), Noramco, Inc., 1440 Olympic 
Drive, Athens, GA 30601, made application by renewal to the Drug 
Enforcement Administration to be registered as a bulk manufacturer of 
the basic classes of controlled substances listed below:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Amphetamine................................  II
Oxycodone (9143)...........................  II
Hydrocodone (9193).........................  II
Morphine (9300)............................  II
Thebaine (9333)............................  II
Sufentanil (9740)..........................  II
Fentanyl (9801)............................  II
------------------------------------------------------------------------

    The firm plans to support its other manufacturing facility with 
manufacturing and analytical testing.
    No comments or objections have been received. DEA has considered 
the factors in Title 21, United States Code, section 823(a) and 
determined that the registration of Noramco, Inc., to manufacture the 
listed controlled substances is consistent with the public interest at 
this time. DEA has investigated Noramco, Inc., to ensure that the 
company's registration is consistent with the public interest. This 
investigation has included inspection and testing of the company's 
physical security systems, verification of the company's compliance 
with state and local laws, and a review of the company's background and 
history. Therefore, pursuant to 21 U.S.C. 823 and 28 CFR 0.100 and 
0.104, the Deputy Assistant Administrator, Office of Diversion Control, 
hereby orders that the application submitted by the above firm for 
registration as a bulk manufacturer of the basic classes of controlled 
substances listed above is granted.

    Dated: June 20, 2003.
Laura M. Nagel,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 03-17126 Filed 7-7-03; 8:45 am]

BILLING CODE 4410-09-M